Cargando…
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
PURPOSE: Prostate-specific membrane antigen (PSMA) targeting therapies such as Lutetium-177 (177Lu)–PSMA-617 are affecting outcomes from metastatic castration-resistant prostate cancer (mCRPC). However, a significant subset of patients have prostate cancer cells lacking PSMA expression, raising conc...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365343/ https://www.ncbi.nlm.nih.gov/pubmed/35552383 http://dx.doi.org/10.1158/1078-0432.CCR-21-4531 |